NF-κB as a Frequent Target for Immunosuppressive and Anti-Inflammatory Molecules**This article was accepted for publication on 27 September 1996.
- 1 January 1997
- book chapter
- Published by Elsevier in Advances in Immunology
- Vol. 65, 111-137
- https://doi.org/10.1016/s0065-2776(08)60742-7
Abstract
No abstract availableThis publication has 92 references indexed in Scilit:
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Immunosuppressive retroviral peptides: cAMP and cytokine patternsImmunology Today, 1995
- Inhibition of NF-κB by Pyrrolidine Dithiocarbamate Blocks Endothelial Cell ActivationBiochemical and Biophysical Research Communications, 1995
- Inhibition of the DNA‐binding activity of NF‐κB by gold compounds in vitroFEBS Letters, 1995
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994
- Inhibition of NF-κB Activation by Vitamin E DerivativesBiochemical and Biophysical Research Communications, 1993
- Fungal infections in cancer patients: An international autopsy surveyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- The mechanism of action of cyclosporin A and FK506Immunology Today, 1992
- A new view of prostaglandin E regulation of the immune responseImmunology Today, 1991
- Review: Mechanisms of action of goldInflammation Research, 1981